Akari Therapeutics (AKTX) EBT (2014 - 2026)
Akari Therapeutics (AKTX) posted EBT of -$15.3 million for Q1 2026, down 193.77% sequentially from -$5.2 million in Q4 2025, and down 313.33% YoY from $7.2 million in Q1 2025.
Akari Therapeutics (AKTX) EBT (2014 - 2026) Analysis & Trends
Akari Therapeutics (AKTX) has 9 years of EBT data on file, last reported at -$15.3 million in Q1 2026.
- Quarterly EBT fell 313.33% year-over-year to -$15.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$31.2 million (down 74.5% YoY) and the FY2025 annual result came in at -$18.3 million, up 7.53% from the prior year.
- EBT declined to -$15.3 million in Q1 2026 per AKTX's latest filing, from -$5.2 million in the prior quarter.
- The five-year high for EBT was -$2.5 million in Q3 2023, with the low at -$15.3 million in Q1 2026.
- Average EBT over 4 years is -$5.5 million, with a median of -$4.6 million recorded in 2023.
- Year-over-year, EBT jumped 57.74% in 2025 and slumped 313.33% in 2026.
- Akari Therapeutics' EBT stood at -$5.1 million in 2023, then increased by 25.79% to -$3.8 million in 2024, then tumbled by 38.2% to -$5.2 million in 2025, then sank by 193.77% to -$15.3 million in 2026.
- Business Quant data shows AKTX's EBT at -$15.3 million in Q1 2026, -$5.2 million in Q4 2025, and -$7.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Genmab A | 276,399.99 Bn | 276,398.47 Bn | 831.00 Mn | 74.00 Mn |
| 2 | Akari Therapeutics | 1,217.26 Bn | 1,217.26 Bn | - | -15.31 Mn |
| 3 | BeOne Medicines | 419.38 Bn | 414.59 Bn | 1.35 Bn | 259.22 Mn |
| 4 | Vertex Pharmaceuticals | 126.54 Bn | 119.30 Bn | 2.59 Bn | 1.25 Bn |
| 5 | Pharming | 110.17 Bn | 110.12 Bn | 65.80 Mn | -4.91 Mn |
| 6 | Regeneron Pharmaceuticals | 64.97 Bn | 56.22 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Argenx Se | 56.44 Bn | 56.44 Bn | 1.18 Bn | 438.00 Mn |
| 8 | Alnylam Pharmaceuticals | 40.09 Bn | 37.08 Bn | 959.66 Mn | 221.65 Mn |
| 9 | Revolution Medicines | 37.15 Bn | 37.15 Bn | - | -453.82 Mn |
| 10 | Moderna | 28.64 Bn | 23.43 Bn | -566.00 Mn | -1.33 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.31 Mn |
| Dec 31, 2025 | -5.21 Mn |
| Sep 30, 2025 | -7.49 Mn |
| Jun 30, 2025 | -3.17 Mn |
| Mar 31, 2025 | -3.71 Mn |
| Dec 31, 2024 | -3.77 Mn |
| Sep 30, 2024 | -2.90 Mn |
| Jun 30, 2024 | -7.50 Mn |
| Mar 31, 2024 | -5.99 Mn |
| Dec 31, 2023 | -5.08 Mn |
| Sep 30, 2023 | -2.49 Mn |
| Jun 30, 2023 | -4.59 Mn |
| Mar 31, 2023 | -4.56 Mn |
| Dec 31, 2020 | -6.89 Mn |
| Sep 30, 2020 | -240,751.00 |
| Jun 30, 2020 | -5.91 Mn |
| Mar 31, 2020 | -4.93 Mn |
| Dec 31, 2019 | -7.82 Mn |
| Sep 30, 2019 | -3.12 Mn |
| Jun 30, 2019 | -6.03 Mn |